References
- Mendes F, Lindor KD. Primary sclerosing cholangitis: overview and update. Nat Rev Gastroenterol Hepatol 2010;7:611–19.
- Broomé U, Bergquist A. Primary sclerosing cholangitis, inflammatory bowel disease, and colon cancer. Semin Liver Dis 2006;26:31–41.
- Karlsen TH, Kaser A. Deciphering the genetic predisposition to primary sclerosing cholangitis. Semin Liver Dis 2011;31:188–207.
- Hov J, Boberg KM, Karlsen TH. Autoantibodies in primary sclerosing cholangitis. WJG 2008;14:3781–91.
- Mandal A, Dasgupta A, Jeffers L, Squillante L, Hyder S, Reddy R, et al. Autoantibodies in sclerosing cholangitis against a shared peptide in biliary and colon epithelium. Gastroenterology 1994;106:185–92.
- Xu B, Broome U, Ericzon B, Sumitran-Holgersson S. High frequency of autoantibodies in patients with primary sclerosing cholangitis that bind biliary epithelial cells and induce expression of CD44 and production of interleukin 6. Gut 2002;51:120–7.
- Woof JM, Russell MW. Structure and function relationships in IgA. Mucosal Immunol 2011;4:590–7.
- Monteiro RC. Role of IgA and IgA fc receptors in inflammation. J Clin Immunol 2010;30:1–9.
- Woof JM, Kerr MA. The function of immunoglobulin A in immunity. J Pathol 2006;208:270–82.
- Chen XM, O'Hara SP, LaRusso NF. The immunobiology of cholangiocytes. Immunol Cell Biol 2008;86:497–505.
- Racanelli V, Rehermann B. The liver as an immunological organ. Hepatology 2006;43:S54–62.
- Robertson H, Kirby J, Yip W, Jones DE, Burt A. Biliary epithelial-mesenchymal transition in posttransplantation recurrence of primary biliary cirrhosis. Hepatology 2007;45:977–81.
- Omenetti A, Porrello A, Jung Y, Yang L, Popov Y, Choi S, et al. Hedgehog signaling regulates epithelial- mesenchymal transition during biliary fibrosis in rodents and humans. J Clin Invest 2008;118:3331–42.
- Kirby J, Robertson H, Marshall H, Rygiel K, Hudson M, Jones DE, et al. Epithelial to mesenchymal transition in primary sclerosing cholangitis. Liver Int 2008;28:1176–7.
- Matsumura S, Van De Water J, Leung P, Odin J, Yamamoto K, Gores G, et al. Caspase induction by IgA antimitochondrial antibody: IgA-mediated biliary injury in primary biliary cirrhosis. Hepatology 2004;39:1415–22.
- Saarinen S, Olerup O, Broomé U. Increased frequency of autoimmune diseases in patients with primary sclerosing cholangitis. Am J Gastroenterol 2000;95:3195–9.
- Bergquist A, Lindberg G, Saarinen S, Broomé U. Increased prevalence of primary sclerosing cholangitis among first- degree relatives. J Hepatol 2005;42:252–6.
- Karlsen TH, Schrumpf E, Boberg KM. Genetic epidemiology of primary sclerosing cholangitis. WJG 2007;13:5421–31.
- Snook JA, Chapman RW, Fleming K, Jewell DP. Anti- neutrophil nuclear antibody in ulcerative colitis, Crohn's disease and primary sclerosing cholangitis. Clin Exp Immunol 1989;76:30–3.
- Terjung B, Bogsch F, Klein R, Söhne J, Reichel C, Wasmuth JC, et al. Diagnostic accuracy of atypical p-ANCA in autoimmune hepatitis using ROC- and multivariate regression analysis. Eur J Med Res 2004;9:439–48.
- Ardesjö B, Portela-Gomes GM, Rorsman F, Grimelius L, Ekwall O. Identification of a novel staining pattern of bile duct epithelial cells in primary sclerosing cholangitis. Inflamm Bowel Dis 2010;16:305–11.
- Schwarze C, Terjung B, Lilienweiss P, Beuers U, Herzog V, Sauerbruch T, et al. IgA class antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis and autoimmune hepatitis. Clin Exp Immunol 2003;133:283–9.
- Kvale D, Schrumpf E, Brandtzaeg P, Solberg HE, Fausa O, Elgjo K. Circulating secretory immunoglobulins of the A and M isotypes in chronic liver disease. J Hepatol 1987;4:229–35.
- Tomita K, Teratani T, Yokoyama H, Suzuki T, Irie R, Ebinuma H, et al. Serum immunoglobulin a concentration is an independent predictor of liver fibrosis in nonalcoholic steatohepatitis before the cirrhotic stage. Dig Dis Sci 2011;56:3648–54.
- Hammerschmidt S, Talay SR, Brandtzaeg P, Chhatwal GS. SpsA, a novel pneumococcal surface protein with specific binding to secretory immunoglobulin A and secretory component. Mol Microbiol 1997;25:1113–24.
- Nielsen OH, Vainer B, Madsen SM, Seidelin JB, Heegaard NH. Established and emerging biological activity markers of inflammatory bowel disease. Am J Gastroenterol 2000;95:359–67.
- Hu CJ, Zhang FC, Li YZ, Zhang X. Primary biliary cirrhosis: what do autoantibodies tell us? WJG 2010;16:3616–29.